ACEL insider plans Rule 144 sale of 12,500 shares, $134.5K value
ACEL reported a planned sale of restricted stock under Rule 144.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
ACEL reported a planned sale of restricted stock under Rule 144. The notice covers 12,500 common shares, to be sold through Morgan Stanley Smith Barney LLC on or about 12/11/2025 on the NYSE, with an aggregate market value of $134,500.00. The class is common stock, and the filing notes that these shares were originally acquired on 07/01/2013 in a SPAC transaction with the issuer.
The notice also lists prior Rule 10b5-1 sales during the past three months, including 12,500 common shares sold for $138,830.00 by GRANT PLACE FUND LLC and another 12,500 common shares sold for $138,830.00 by CRILLY COURT TRUST on 09/15/2025. The issuer has 83,207,946 common shares outstanding, which provides a baseline for the relative size of these planned and recent sales.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does ACEL's latest Form 144 filing disclose?
AI-generated analysis. How Rhea-AI works. Not financial advice.